212 related articles for article (PubMed ID: 28699031)
21. Cyclosporine experience in nephrotic syndrome.
Phadke K; Ballal S; Maiya V
Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
[TBL] [Abstract][Full Text] [Related]
22. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].
Vavić N; Ignjatović L; Drasković B; Hrvacević R; Kovacević Z; Paunić Z
Vojnosanit Pregl; 2008 Feb; 65(2):119-27. PubMed ID: 18365668
[TBL] [Abstract][Full Text] [Related]
24. Age effect on whole blood cyclosporine concentrations following oral administration in children with nephrotic syndrome.
Ushijima K; Uemura O; Yamada T
Eur J Pediatr; 2012 Apr; 171(4):663-8. PubMed ID: 22116269
[TBL] [Abstract][Full Text] [Related]
25. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A; Hari P; Moudgil A; Jordan SC
Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
[TBL] [Abstract][Full Text] [Related]
27. Long-term clinical and pathological effects of cyclosporin in children with nephrosis.
Seikaly MG; Prashner H; Nolde-Hurlbert B; Browne R
Pediatr Nephrol; 2000 Mar; 14(3):214-7. PubMed ID: 10752760
[TBL] [Abstract][Full Text] [Related]
28. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
Aizawa-Yashiro T; Tsuruga K; Watanabe S; Oki E; Ito E; Tanaka H
Pediatr Nephrol; 2011 Aug; 26(8):1255-61. PubMed ID: 21479767
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
Aksu N; Türker M; Erdoğan H; Ozinel S; Kansoy S
Turk J Pediatr; 1999; 41(2):225-30. PubMed ID: 10770662
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome.
Hoseini R; Sabzian K; Otukesh H; Zafaranloo N; Panahi P; Rahimzadeh N; Nakhaie S; Akhavan Sepehi M
Iran J Kidney Dis; 2018 Jan; 12(1):27-32. PubMed ID: 29421774
[TBL] [Abstract][Full Text] [Related]
32. Comparison between pre- and posttreatment clinical and renal biopsies in children receiving low dose ciclosporine-A for 2 years for steroid-dependent nephrotic syndrome.
Kano K; Kyo K; Yamada Y; Ito S; Ando T; Arisaka O
Clin Nephrol; 1999 Jul; 52(1):19-24. PubMed ID: 10442491
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome.
Kengne-Wafo S; Massella L; Diomedi-Camassei F; Gianviti A; Vivarelli M; Greco M; Stringini GR; Emma F
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1409-16. PubMed ID: 19628686
[TBL] [Abstract][Full Text] [Related]
34. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
[TBL] [Abstract][Full Text] [Related]
35. What is The Best Choice in Steroid-Dependent Nephrotic Syndrome: Mycophenolate Mofetil Plus Dexamethasone or Cyclosporine A.
Tunçay SC; Mir S; Hakverdi G
Saudi J Kidney Dis Transpl; 2021; 32(4):1019-1027. PubMed ID: 35229801
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome.
Rinaldi S; Sesto A; Barsotti P; Faraggiana T; Sera F; Rizzoni G
Pediatr Nephrol; 2005 Jan; 20(1):25-9. PubMed ID: 15602664
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
Okada M; Sugimoto K; Yagi K; Yanagida H; Tabata N; Takemura T
Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300
[TBL] [Abstract][Full Text] [Related]
38. Predictive factors for ciclosporin-associated nephrotoxicity in children with minimal change nephrotic syndrome.
Kim JH; Park SJ; Yoon SJ; Lim BJ; Jeong HJ; Lee JS; Kim PK; Shin JI
J Clin Pathol; 2011 Jun; 64(6):516-9. PubMed ID: 21441261
[TBL] [Abstract][Full Text] [Related]
39. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil.
Gellermann J; Querfeld U
Pediatr Nephrol; 2004 Jan; 19(1):101-4. PubMed ID: 14753204
[TBL] [Abstract][Full Text] [Related]
40. Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial.
Iijima K; Sako M; Oba MS; Ito S; Hataya H; Tanaka R; Ohwada Y; Kamei K; Ishikura K; Yata N; Nozu K; Honda M; Nakamura H; Nagata M; Ohashi Y; Nakanishi K; Yoshikawa N;
Clin J Am Soc Nephrol; 2014 Feb; 9(2):271-8. PubMed ID: 24262503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
